B-condition	0	6	Seroma
O	7	17	prevention
O	18	27	following
B-intervention	28	36	axillary
I-intervention	37	47	dissection
O	48	50	in
O	51	59	patients
O	60	64	with
O	65	71	breast
O	72	78	cancer
O	79	81	by
O	82	87	using
O	88	98	ultrasound
O	99	107	scissors
O	107	108	:
O	109	110	a
O	111	122	prospective
O	123	131	clinical
O	132	137	study
O	137	138	.

O	139	145	Seroma
O	146	155	formation
O	156	165	following
O	166	174	axillary
O	175	185	dissection
O	186	188	is
O	189	190	a
O	191	197	common
O	198	210	complication
O	211	213	of
O	214	220	breast
O	221	228	surgery
O	228	229	.

O	230	233	The
O	234	238	aims
O	239	241	of
O	242	246	this
O	247	252	study
O	253	257	were
O	258	259	(
O	259	260	1
O	260	261	)
O	262	264	to
O	265	272	analyse
O	273	276	the
O	277	281	risk
O	282	289	factors
O	290	292	of
O	293	299	seroma
O	300	309	formation
O	309	310	,
O	311	314	and
O	315	316	(
O	316	317	2
O	317	318	)
O	319	321	to
O	322	330	evaluate
O	331	334	the
O	335	339	role
O	340	342	of
O	343	353	ultrasound
O	354	362	scissors
O	363	365	in
O	366	376	performing
O	377	385	axillary
O	386	396	dissection
O	397	399	in
O	400	408	patients
O	409	413	with
O	414	421	primary
O	422	428	breast
O	429	435	cancer
O	436	446	undergoing
O	447	457	mastectomy
O	458	461	and
O	462	468	breast
O	468	469	-
O	469	479	conserving
O	480	487	surgery
O	487	488	.

B-total-participants	489	495	Ninety
I-total-participants	495	496	-
I-total-participants	496	499	two
O	500	505	women
O	506	507	(
O	507	513	median
O	514	517	age
B-age	518	520	55
I-age	521	526	years
O	526	527	,
O	528	533	range
O	534	536	33
O	536	537	-
O	537	539	73
O	540	545	years
O	545	546	)
B-eligibility	547	556	requiring
I-eligibility	557	564	surgery
I-eligibility	565	568	for
I-eligibility	569	574	known
I-eligibility	575	585	unilateral
I-eligibility	586	593	primary
I-eligibility	594	600	breast
I-eligibility	601	607	cancer
I-eligibility	608	609	(
I-eligibility	609	613	pT1a
I-eligibility	613	614	=
I-eligibility	614	615	1
I-eligibility	615	616	,
I-eligibility	617	621	pT1b
I-eligibility	621	622	=
I-eligibility	622	624	20
I-eligibility	624	625	,
I-eligibility	626	630	pT1c
I-eligibility	630	631	=
I-eligibility	631	633	43
I-eligibility	633	634	,
I-eligibility	635	638	pT2
I-eligibility	638	639	=
I-eligibility	639	641	25
I-eligibility	641	642	,
I-eligibility	643	646	pT3
I-eligibility	646	647	=
I-eligibility	647	648	3
I-eligibility	648	649	)
O	650	654	were
O	655	668	prospectively
O	669	679	randomised
O	680	682	to
O	683	690	undergo
O	691	699	axillary
O	700	710	dissection
O	711	713	by
O	714	720	either
O	721	726	using
O	727	728	(
O	728	733	Group
O	734	735	A
O	735	736	,
B-intervention-participants	737	739	45
O	740	748	patients
O	748	749	)
O	750	752	or
B-control	753	756	not
I-control	757	762	using
O	763	764	(
O	764	769	Group
O	770	771	B
O	771	772	,
B-control-participants	773	775	47
O	776	784	patients
O	784	785	)
O	786	796	ultrasound
O	797	805	scissors
O	806	807	(
O	807	809	US
O	809	810	)
O	810	811	.

O	812	818	Thirty
O	818	819	-
O	819	824	eight
O	825	826	(
O	826	828	41
O	828	829	.
O	829	830	3
O	830	831	%
O	831	832	)
O	833	841	patients
O	842	851	underwent
O	852	860	modified
O	861	868	radical
O	869	879	mastectomy
O	879	880	,
O	881	886	while
O	887	889	54
O	890	891	(
O	891	893	58
O	893	894	.
O	894	895	7
O	895	896	%
O	896	897	)
O	898	907	underwent
O	908	914	breast
O	914	915	-
O	915	925	conserving
O	926	933	surgery
O	933	934	.

O	935	941	Twenty
O	941	942	-
O	942	947	eight
O	948	949	(
O	949	951	30
O	951	952	.
O	952	953	4
O	953	954	%
O	954	955	)
O	956	964	patients
O	965	966	(
O	966	971	Group
O	972	973	A
O	973	974	=
B-iv-bin-abs	974	975	9
O	976	979	out
O	980	982	of
B-intervention-participants	983	985	45
O	985	986	,
B-iv-bin-percent	987	989	20
I-iv-bin-percent	989	990	%
O	990	991	;
O	992	997	Group
O	998	999	B
O	999	1000	=
B-cv-bin-abs	1000	1002	19
O	1003	1006	out
O	1007	1009	of
B-control-participants	1010	1012	47
O	1012	1013	,
B-cv-bin-percent	1014	1016	42
I-cv-bin-percent	1016	1017	%
O	1017	1018	;
O	1019	1020	P
O	1020	1021	=
O	1021	1023	NS
O	1023	1024	)
B-outcome	1025	1034	developed
I-outcome	1035	1036	a
I-outcome	1037	1042	wound
I-outcome	1043	1049	seroma
O	1049	1050	.

O	1051	1063	Multivariate
O	1064	1072	analysis
O	1073	1078	using
O	1079	1080	a
O	1081	1089	logistic
O	1090	1100	regression
O	1101	1106	model
O	1107	1113	showed
O	1114	1118	that
B-outcome	1119	1127	surgical
I-outcome	1128	1137	procedure
O	1138	1139	(
O	1139	1141	RR
O	1141	1142	=
O	1142	1143	8
O	1143	1144	.
O	1144	1145	9
O	1145	1146	;
O	1147	1149	95
O	1149	1150	%
O	1151	1153	CI
O	1153	1154	:
O	1155	1156	3
O	1156	1157	.
O	1157	1158	2
O	1158	1159	-
O	1159	1161	25
O	1161	1162	.
O	1162	1163	3
O	1163	1164	)
O	1164	1165	,
B-outcome	1166	1171	total
I-outcome	1172	1178	amount
I-outcome	1179	1181	of
I-outcome	1182	1190	drainage
O	1191	1192	(
O	1192	1194	RR
O	1194	1195	=
O	1195	1196	7
O	1196	1197	.
O	1197	1198	8
O	1198	1199	;
O	1200	1202	95
O	1202	1203	%
O	1204	1206	CI
O	1206	1207	:
O	1208	1209	2
O	1209	1210	.
O	1210	1211	8
O	1211	1212	-
O	1212	1214	22
O	1214	1215	.
O	1215	1216	0
O	1216	1217	)
O	1217	1218	,
O	1219	1222	and
B-outcome	1223	1227	size
I-outcome	1228	1230	of
I-outcome	1231	1234	the
I-outcome	1235	1241	tumour
O	1242	1243	(
O	1243	1245	RR
O	1245	1246	=
O	1246	1247	6
O	1247	1248	.
O	1248	1249	0
O	1249	1250	;
O	1251	1253	95
O	1253	1254	%
O	1255	1257	CI
O	1257	1258	:
O	1259	1260	2
O	1260	1261	.
O	1261	1262	2
O	1262	1263	-
O	1263	1265	16
O	1265	1266	.
O	1266	1267	5
O	1267	1268	)
O	1269	1282	independently
O	1283	1293	correlated
O	1294	1298	with
O	1299	1305	seroma
O	1306	1315	formation
O	1315	1316	.

O	1317	1320	The
O	1321	1329	logistic
O	1330	1340	regression
O	1341	1349	function
O	1350	1351	(
O	1351	1353	RR
O	1353	1354	=
O	1354	1356	19
O	1356	1357	.
O	1357	1358	4
O	1358	1359	;
O	1360	1362	95
O	1362	1363	%
O	1364	1366	CI
O	1366	1367	:
O	1368	1369	6
O	1369	1370	-
O	1370	1372	62
O	1372	1373	)
O	1374	1383	correctly
O	1384	1393	allocated
O	1394	1396	75
O	1397	1400	out
O	1401	1403	of
O	1404	1406	92
O	1407	1408	(
O	1408	1410	81
O	1410	1411	.
O	1411	1412	5
O	1412	1413	%
O	1413	1414	)
O	1415	1423	patients
O	1423	1424	.

O	1425	1429	Size
O	1430	1432	of
O	1433	1436	the
O	1437	1443	tumour
O	1443	1444	,
O	1445	1448	and
O	1449	1454	total
O	1455	1461	amount
O	1462	1464	of
O	1465	1473	drainage
O	1474	1483	represent
O	1484	1487	the
O	1488	1497	principal
O	1498	1505	factors
O	1506	1508	of
O	1509	1515	seroma
O	1516	1525	formation
O	1526	1535	following
O	1536	1544	axillary
O	1545	1555	dissection
O	1556	1558	in
O	1559	1567	patients
O	1568	1578	undergoing
O	1579	1586	surgery
O	1587	1590	for
O	1591	1597	breast
O	1598	1604	cancer
O	1604	1605	.

O	1606	1614	Although
O	1615	1618	the
O	1619	1622	use
O	1623	1625	of
O	1626	1636	ultrasound
O	1637	1644	cutting
O	1645	1652	devices
O	1653	1656	may
O	1657	1663	reduce
O	1664	1667	the
O	1668	1672	risk
O	1673	1675	of
O	1676	1682	seroma
O	1683	1692	formation
O	1692	1693	,
O	1694	1701	further
O	1702	1709	studies
O	1710	1713	are
O	1714	1718	need
O	1719	1721	to
O	1722	1728	verify
O	1729	1732	the
O	1733	1737	real
O	1738	1744	impact
O	1745	1747	on
O	1748	1752	long
O	1752	1753	-
O	1753	1757	term
O	1758	1767	morbidity
O	1768	1770	of
O	1771	1775	such
O	1776	1785	technique
O	1785	1786	.
